News & Events about Codexis Inc.
Simply Wall St
4 months ago
It's not a secret that every investor will make bad investments, from time to time. But it should be a priority to...
Ticker Report
5 months ago
Skandinaviska Enskilda Banken AB publ cut its stake in Codexis, Inc. (NASDAQ:CDXS Get Rating) by 23.6% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 62,375 shares of the biotechnology ...
Globe Newswire
7 months ago
Collaboration with Merck published in Science magazine REDWOOD CITY, Calif., June 17, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announces the publication with Merck, known as MSD outside the United ...
Ticker Report
8 months ago
Qube Research Technologies Ltd reduced its position in Codexis, Inc. (NASDAQ:CDXS Get Rating) by 32.3% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 22,827 shares of the biotechnology companys stock after selling ...